Konstantin Zhernosekov

2.2k citations

33 papers · 1.7k indexed · 1 hit paper · h-index 19

Radiology, Nuclear Medicine and Imaging top 1%
- Radiopharmaceutical Chemistry and Applications 25
- Medical Imaging Techniques and Applications 14
Radiation top 5%
- Nuclear Physics and Applications 3
Pulmonary and Respiratory Medicine top 5%
- Medical Imaging and Pathology Studies 5
- Prostate Cancer Treatment and Research 4
- Lung Cancer Treatments and Mutations 3
Oncology top 5%
Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 10
Neurology
- Neuroblastoma Research and Treatments 3

Co-authors: Roger Schibli Cristina Müller Α. Türler Frank Rösch D. V. Filosofov Holger Dorrer U. Köster Richard P. Baum
Cited by: Radiology, Nuclear Medicine and Imaging Radiation Pulmonary and Respiratory Medicine
Partner nations: Germany Switzerland France

In The Last Decade

Konstantin Zhernosekov

32 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Konstantin Zhernosekov

Since Specialization

Citations

This map shows the geographic impact of Konstantin Zhernosekov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantin Zhernosekov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantin Zhernosekov more than expected).

Fields of papers citing papers by Konstantin Zhernosekov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantin Zhernosekov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantin Zhernosekov. The network helps show where Konstantin Zhernosekov may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Konstantin Zhernosekov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Konstantin Zhernosekov Line = papers co-authored together Konstantin Zhernosekov links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Biodistribution and dosimetry of [177Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer Philipp Ritt,René Fernández,Cristian Soza‐Ried,Heinz Nicolai,Horacio Amaral,Korbinian Krieger,Ana Katrina Mapanao,Amanda Rotger,Konstantin Zhernosekov,Roger Schibli,Cristina Müller,Vasko Kramer	2025	3
2	Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model Marian Meckel,Stefanie Ehrenberg,Theresa Schmidt,Philipp Ritt,Margret I. Moré,Ralf Bergmann,Domokos Máthé,Konstantin Zhernosekov	2025	0
3	The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next? Philip E. Harris,Konstantin Zhernosekov	2022	38
4	Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity Luisa M. Deberle,Martina Benešová,Christoph A. Umbricht,Francesca Borgna,Manuel Büchler,Konstantin Zhernosekov,Roger Schibli,Cristina Müller	2020	72
5	Development of a [ ¹⁷⁷ Lu]BPAMD Labeling Kit and an Automated Synthesis Module for Routine Bone Targeted Endoradiotherapy Marian Meckel,Aaron Nauth,J. T. Timpe,Konstantin Zhernosekov,Ameya Puranik,Richard P. Baum,Frank Rösch	2015	17
6	Radiosynthesis of clinical doses of 68 Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based 68 Ge/ 68 Ga generators Izabela Tworowska,David Ranganathan,Sanjay Thamake,Ebrahim S. Delpassand,Alireza Mojtahedi,Michael K. Schultz,Konstantin Zhernosekov,Sebastian Marx	2015	23
7	Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model Jürgen Grünberg,Dennis Lindenblatt,Holger Dorrer,Susan Cohrs,Konstantin Zhernosekov,U. Köster,Α. Türler,Eliane Fischer,Roger Schibli	2014	59
8	Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate Cristina Müller,Josefine Reber,Stephanie Haller,Holger Dorrer,Peter Bernhardt,Konstantin Zhernosekov,Α. Türler,Roger Schibli	2013	103
9	Promises of Cyclotron-Produced ⁴⁴Sc as a Diagnostic Match for Trivalent β⁻-Emitters: In Vitro and In Vivo Study of a ⁴⁴Sc-DOTA-Folate Conjugate Cristina Müller,Maruta Bunka,Josefine Reber,Cindy R. Fischer,Konstantin Zhernosekov,Α. Türler,Roger Schibli	2013	94
10	A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β⁻-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative Cristina Müller,Konstantin Zhernosekov,U. Köster,K. Johnston,Holger Dorrer,Alexander Höhn,Nico T. van der Walt,Α. Türler,Roger Schibli	2012	189
11	DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted ¹⁷⁷Lu-Radionuclide Tumor Therapy in Mice Cristina Müller,Harriet Struthers,Christian Winiger,Konstantin Zhernosekov,Roger Schibli	2012	157
12	The Szilard–Chalmers effect in macrocyclic ligands to increase the specific activity of reactor-produced radiolanthanides: Experiments and explanations Konstantin Zhernosekov,D. V. Filosofov,Frank Rösch	2012	7
13	Development and evaluation of (44)Ti production on high energy protons Konstantin Zhernosekov,Maruta Bunka,Alexander Höhn,Roger Schibli,Α. Türler	2011	1
14	Conceptual Design, Neutronic and Radioprotection Study of a Fast Neutron Irradiation Station at SINQ L. Zanini,N. Baluc,Andrea De Simone,R. Eichler,St. Joray,Enzo Manfrin,M.A. Pouchon,S. Rabaioli,D. Schumann,J. Welte,Konstantin Zhernosekov	2011	1
15	The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy Silvia Lehenberger,Christoph Barkhausen,Susan Cohrs,Eliane Fischer,Jürgen Grünberg,Alexander Höhn,U. Köster,Roger Schibli,Α. Türler,Konstantin Zhernosekov	2011	128
16	Improved column-based radiochemical processing of the generator produced 68Ga Natalia S. Loktionova,Andrey N. Belozub,D.V. Filosofov,Konstantin Zhernosekov,Thomas C. Wagner,Α. Türler,Frank Rösch	2011	32
17	Target burn-up corrected specific activity of 177Lu produced via 176Lu(n, γ) 177Lu nuclear reactions Konstantin Zhernosekov,R. C. Perego,Z. Dvorakova,R. Henkelmann,Α. Türler	2008	24
18	Processing of Generator-Produced 68Ga for Medical Applicationbreakdown → Konstantin Zhernosekov,D. V. Filosofov,Richard P. Baum,P. Aschoff,H. Bihl,A. A. Razbash,Markus Jahn,M. Jennewein,Frank Rösch	2007	419
19	Visualisation of a somatostatin receptor-expressing tumour with 67Ga-DOTATOC SPECT Konstantin Zhernosekov,P. Aschoff,D. Filosofov,Markus Jahn,M. Jennewein,Hans-J�rgen Adrian,H. Bihl,Frank Rösch	2005	9
20	Complex formation of Tb³⁺with glycolate,D-gluconate andα-isosaccharinate in neutral aqueous perchlorate solutions Konstantin Zhernosekov,Eric Mauerhofer,Gedion Getahun,P. Warwick,Frank Rösch	2003	6

About Konstantin Zhernosekov

Konstantin Zhernosekov is a scholar working on Radiology, Nuclear Medicine and Imaging, Filtration and Separation and Radiation, having authored 33 papers that have together received 1.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (25 papers), Medical Imaging Techniques and Applications (14 papers), Neuroendocrine Tumor Research Advances (10 papers), Medical Imaging and Pathology Studies (5 papers), Prostate Cancer Treatment and Research (4 papers), Neuroblastoma Research and Treatments (3 papers), Nuclear Physics and Applications (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.3k citations), Radiation (183 citations) and Pulmonary and Respiratory Medicine (607 citations). Konstantin Zhernosekov has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include Roger Schibli, Cristina Müller, Α. Türler, Frank Rösch, D. V. Filosofov, Holger Dorrer, U. Köster, Richard P. Baum, H. Bihl and Markus Jahn.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact